Market Analysis and Insights:
The global Zebrafish market size is projected to reach US$ 231.50 million by 2028, from US$ 89.65 million in 2021, at a CAGR of 14.51% during 2022-2028.
China Zebrafish market size is valued at US$ 14.24 million in 2021, while the North America and Europe Zebrafish are US$ 24.48 million and US$ 22.48 million, severally. The proportion of the North America is 27.30% in 2021, while Europe is 25.07% respectively, and it is predicted that Europe proportion will reach 22.77% in 2028, trailing a CAGR of 12.59% through the analysis period. As for the Europe Zebrafish landscape, Germany is projected to reach US$ 11.61 million by 2028 trailing a CAGR of 13.20% over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Zebrafish market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Zebrafish market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Zebrafish market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Zebrafish market.
Scope and Market Size:
Zebrafish market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Zebrafish market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
By Company
- Shanghai Model Organisms Center, Inc.
- ZeClinics
- InVivo Biosystems
- Biobide
- Pentagrit
- Evotec
- Aurigene Pharmaceutical Services
- ikanbiotech
- Bioreperia
- Hangzhou Hunter Biotechnology Co., Ltd.
- YSY BIOTECH
- Eze-Rinka
- INVENesis
- FEIFAN TEST
- Charles River Laboratories
Segment by Application
- Pharmaceutical
- Biotechnology
- Agrochemical Research
- Cosmetics
- Water Quality Monitoring
- Others
By Region
- North America
- Asia-Pacific
- Europe
- South America
- Middle East & Africa
TABLE OF CONTENTS
1 REPORT OVERVIEW
- 1.1 STUDY SCOPE
- 1.2 MARKET BY APPLICATION
- 1.2.1 GLOBAL ZEBRAFISH MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028
- 1.2.2 PHARMACEUTICAL (DRUG DISCOVERY, PHARMA RESEARCH)
- 1.2.3 BIOTECHNOLOGY
- 1.2.4 AGROCHEMICAL RESEARCH
- 1.2.5 COSMETICS
- 1.2.6 WATER QUALITY MONITORING
- 1.2.7 OTHERS
- 1.3 STUDY OBJECTIVES
- 1.4 YEARS CONSIDERED
2 GLOBAL GROWTH TRENDS
- 2.1 GLOBAL ZEBRAFISH MARKET PERSPECTIVE (2017-2028)
- 2.2 ZEBRAFISH GROWTH TRENDS BY REGION
- 2.2.1 ZEBRAFISH MARKET SIZE BY REGION: 2017 VS 2021 VS 2028
- 2.2.2 ZEBRAFISH HISTORIC MARKET SIZE BY REGION (2017-2022)
- 2.2.3 ZEBRAFISH FORECASTED MARKET SIZE BY REGION (2023-2028)
- 2.3 ZEBRAFISH MARKET DYNAMICS
- 2.3.1 ZEBRAFISH INDUSTRY TRENDS
- 2.3.2 ZEBRAFISH MARKET DRIVERS
- 2.3.3 ZEBRAFISH MARKET CHALLENGES
- 2.3.4 ZEBRAFISH MARKET RESTRAINTS
3 COMPETITION LANDSCAPE BY KEY PLAYERS
- 3.1 GLOBAL TOP ZEBRAFISH PLAYERS BY REVENUE
- 3.1.1 GLOBAL TOP ZEBRAFISH PLAYERS BY REVENUE (2017-2022)
- 3.1.2 GLOBAL ZEBRAFISH REVENUE MARKET SHARE BY PLAYERS (2017-2022)
- 3.2 GLOBAL ZEBRAFISH MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3)
- 3.3 PLAYERS COVERED: RANKING BY ZEBRAFISH REVENUE
- 3.4 GLOBAL ZEBRAFISH MARKET CONCENTRATION RATIO
- 3.4.1 GLOBAL ZEBRAFISH MARKET CONCENTRATION RATIO (CR5 AND HHI)
- 3.4.2 GLOBAL TOP 10 AND TOP 5 COMPANIES BY ZEBRAFISH REVENUE IN 2021
- 3.5 MERGERS & ACQUISITIONS, EXPANSION PLANS
4 ZEBRAFISH BREAKDOWN DATA BY APPLICATION
- 4.1 GLOBAL ZEBRAFISH HISTORIC MARKET SIZE BY APPLICATION (2017-2022)
- 4.2 GLOBAL ZEBRAFISH FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
5 NORTH AMERICA
- 5.1 NORTH AMERICA ZEBRAFISH MARKET SIZE BY COUNTRY (2017-2028)
- 5.2 UNITED STATES
- 5.3 CANADA
- 5.4 MEXICO
6 EUROPE
- 6.1 EUROPE ZEBRAFISH MARKET SIZE BY COUNTRY (2017-2028)
- 6.2 GERMANY
- 6.3 FRANCE
- 6.4 U.K.
- 6.5 ITALY
- 6.6 RUSSIA
- 6.7 REST OF EUROPE
7 ASIA-PACIFIC
- 7.1 ASIA-PACIFIC ZEBRAFISH MARKET SIZE BY REGION (2017-2028)
- 7.2 CHINA
- 7.3 JAPAN
- 7.4 SOUTH KOREA
- 7.5 SOUTHEAST ASIA
- 7.6 INDIA
- 7.7 REST OF ASIA-PACIFIC
8 SOUTH AMERICA
- 8.1 SOUTH AMERICA ZEBRAFISH MARKET SIZE BY COUNTRY (2017-2028)
- 8.2 BRAZIL
- 8.3 ARGENTINA
- 8.4 REST OF SOUTH AMERICA
9 MIDDLE EAST & AFRICA
- 9.1 MIDDLE EAST & AFRICA ZEBRAFISH MARKET SIZE BY COUNTRY
- 9.2 SAUDI ARABIA
- 9.3 UAE
- 9.4 REST OF MIDDLE EAST & AFRICA
10 KEY PLAYERS PROFILES
- 10.1 SHANGHAI MODEL ORGANISMS CENTER, INC.
- 10.1.1 SHANGHAI MODEL ORGANISMS CENTER, INC. COMPANY DETAILS
- 10.1.2 SHANGHAI MODEL ORGANISMS CENTER, INC. BUSINESS OVERVIEW
- 10.1.3 SHANGHAI MODEL ORGANISMS CENTER, INC. ZEBRAFISH INTRODUCTION
- 10.1.4 SHANGHAI MODEL ORGANISMS CENTER, INC. REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.1.5 SHANGHAI MODEL ORGANISMS CENTER, INC. RECENT DEVELOPMENT
- 10.2 ZECLINICS
- 10.2.1 ZECLINICS COMPANY DETAILS
- 10.2.2 ZECLINICS BUSINESS OVERVIEW
- 10.2.3 ZECLINICS ZEBRAFISH INTRODUCTION
- 10.2.4 ZECLINICS REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.2.5 ZECLINICS RECENT DEVELOPMENT
- 10.3 INVIVO BIOSYSTEMS
- 10.3.1 INVIVO BIOSYSTEMS COMPANY DETAILS
- 10.3.2 INVIVO BIOSYSTEMS BUSINESS OVERVIEW
- 10.3.3 INVIVO BIOSYSTEMS ZEBRAFISH INTRODUCTION
- 10.3.4 INVIVO BIOSYSTEMS REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.3.5 INVIVO BIOSYSTEMS RECENT DEVELOPMENT
- 10.4 BIOBIDE
- 10.4.1 BIOBIDE COMPANY DETAILS
- 10.4.2 BIOBIDE BUSINESS OVERVIEW
- 10.4.3 BIOBIDE ZEBRAFISH INTRODUCTION
- 10.4.4 BIOBIDE REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.5 PENTAGRIT
- 10.5.1 PENTAGRIT COMPANY DETAILS
- 10.5.2 PENTAGRIT BUSINESS OVERVIEW
- 10.5.3 PENTAGRIT ZEBRAFISH INTRODUCTION
- 10.5.4 PENTAGRIT REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.5.5 PENTAGRIT RECENT DEVELOPMENT
- 10.6 EVOTEC
- 10.6.1 EVOTEC COMPANY DETAILS
- 10.6.2 EVOTEC BUSINESS OVERVIEW
- 10.6.3 EVOTEC ZEBRAFISH INTRODUCTION
- 10.6.4 EVOTEC REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.6.5 EVOTEC RECENT DEVELOPMENT
- 10.7 AURIGENE PHARMACEUTICAL SERVICES
- 10.7.1 AURIGENE PHARMACEUTICAL SERVICES COMPANY DETAILS
- 10.7.2 AURIGENE PHARMACEUTICAL SERVICES BUSINESS OVERVIEW
- 10.7.3 AURIGENE PHARMACEUTICAL SERVICES ZEBRAFISH INTRODUCTION
- 10.7.4 AURIGENE PHARMACEUTICAL SERVICES REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.7.5 AURIGENE PHARMACEUTICAL SERVICES RECENT DEVELOPMENT
- 10.8 IKANBIOTECH
- 10.8.1 IKANBIOTECH COMPANY DETAILS
- 10.8.2 IKANBIOTECH BUSINESS OVERVIEW
- 10.8.3 IKANBIOTECH ZEBRAFISH INTRODUCTION
- 10.8.4 IKANBIOTECH REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.8.5 IKANBIOTECH RECENT DEVELOPMENT
- 10.9 BIOREPERIA
- 10.9.1 BIOREPERIA COMPANY DETAILS
- 10.9.2 BIOREPERIA BUSINESS OVERVIEW
- 10.9.3 BIOREPERIA ZEBRAFISH INTRODUCTION
- 10.9.4 BIOREPERIA REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.9.5 BIOREPERIA RECENT DEVELOPMENT
- 10.10 HANGZHOU HUNTER BIOTECHNOLOGY CO., LTD.
- 10.10.1 HANGZHOU HUNTER BIOTECHNOLOGY CO., LTD. COMPANY DETAILS
- 10.10.2 HANGZHOU HUNTER BIOTECHNOLOGY CO., LTD. BUSINESS OVERVIEW
- 10.10.3 HANGZHOU HUNTER BIOTECHNOLOGY CO., LTD. ZEBRAFISH INTRODUCTION
- 10.10.4 HANGZHOU HUNTER BIOTECHNOLOGY CO., LTD. REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.10.5 HANGZHOU HUNTER BIOTECHNOLOGY CO., LTD. RECENT DEVELOPMENT
- 10.11 YSY BIOTECH
- 10.11.1 YSY BIOTECH COMPANY DETAILS
- 10.11.2 YSY BIOTECH BUSINESS OVERVIEW
- 10.11.3 YSY BIOTECH ZEBRAFISH INTRODUCTION
- 10.11.4 YSY BIOTECH REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.12 EZE-RINKA
- 10.12.1 EZE-RINKA COMPANY DETAILS
- 10.12.2 EZE-RINKA BUSINESS OVERVIEW
- 10.12.3 EZE-RINKA ZEBRAFISH INTRODUCTION
- 10.12.4 EZE-RINKA REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.13 INVENESIS
- 10.13.1 INVENESIS COMPANY DETAILS
- 10.13.2 INVENESIS BUSINESS OVERVIEW
- 10.13.3 INVENESIS ZEBRAFISH INTRODUCTION
- 10.13.4 INVENESIS REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.13.5 INVENESIS RECENT DEVELOPMENT
- 10.14 FEIFAN TEST
- 10.14.1 FEIFAN TEST COMPANY DETAILS
- 10.14.2 FEIFAN TEST BUSINESS OVERVIEW
- 10.14.3 FEIFAN TEST ZEBRAFISH INTRODUCTION
- 10.14.4 FEIFAN TEST REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.15 CHARLES RIVER LABORATORIES
- 10.15.1 CHARLES RIVER LABORATORIES COMPANY DETAILS
- 10.15.2 CHARLES RIVER LABORATORIES BUSINESS OVERVIEW
- 10.15.3 CHARLES RIVER LABORATORIES ZEBRAFISH INTRODUCTION
- 10.15.4 CHARLES RIVER LABORATORIES REVENUE IN ZEBRAFISH BUSINESS (2017-2022)
- 10.15.5 CHARLES RIVER LABORATORIES RECENT DEVELOPMENT
11 ANALYST'S VIEWPOINTS/CONCLUSIONS
12 APPENDIX
- 12.1 RESEARCH METHODOLOGY
- 12.1.1 METHODOLOGY/RESEARCH APPROACH
- 12.1.2 DATA SOURCE
- 12.2 DISCLAIMER
- 12.3 AUTHOR DETAILS